Merrimack Announces Formation of New Scientific Advisory Board with Extensive Expertise in Precision Oncology

Members include world-renowned experts in biomarker-defined cancers, bioengineering, drug discovery and clinical development CAMBRIDGE, Mass., Feb. 20, 2018 -- (Healthcare Sales & Marketing Network) -- Merrimack Pharmaceuticals (Nasdaq: MACK), a clinic... Biopharmaceuticals, Oncology, Personnel Merrimack Pharmaceuticals
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news